Survival Analysis
Novartis announces NEJM publication of updated analysis from ELIANA trial showing longer-term durable remissions with Kymriah(TM) in children, young adults with r/r ALL
Let's Flip: An Approach to Understand Median Follow-up by the Reverse Kaplan-Meier Estimator from a Statistical Programmer's
Survival Analysis in R
Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors | Scientific Reports
Overall survival for suPAR levels above or below a 12 ng/mL cutoff.... | Download Scientific Diagram
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
Kaplan-Meier survival analysis
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
The overall survival did not reach median. The median progression free... | Download Scientific Diagram
Median Survival Time - an overview | ScienceDirect Topics
a Kaplan?Meier relapse-free survival (median follow-up time 42 months)... | Download Scientific Diagram
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
GraphPad Prism 10 Statistics Guide - Determining the median followup time
primed.info
Example Kaplan-Meier (KM) curves of overall survival (OS) from an... | Download Scientific Diagram
a Kaplan–Meier survival curve with a median follow-up time of... | Download Scientific Diagram
Survival Analysis in R
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time | Scientific Reports
survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Finding median survival time from survival function - Cross Validated
How Median Follow-up Time Informs Survival Outcomes: Lessons from a Trial of Acute Myeloid Patients Treated with Venetoclax and Azacitidine - ScienceDirect
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
Let's Flip: An Approach to Understand Median Follow-up by the Reverse Kaplan-Meier Estimator from a Statistical Programmer's
Survival Analysis
